bioAffinity Technologies (BIAF) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
Insiders put their own money in: $1.0M of open-market buys against $1.2M of sales. See how similar setups did below.
Label: Net buying · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.Sale HRT Financial LP, 10% Owner sold 41,529 shares at $6.45 ($268K).
- Trade date
- Oct 1, 2026
- Disclosed to the SEC
- Nov 19, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All BIAF insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
BIAF insider transactions (Form 4)
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 41,529116,658 held (−26%) | $6.45 | $268K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 30,065131,221 held (+30%) | $7.67 | $231K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 27,246131,221 held (−17%) | $7.75 | $211K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 18,929126,519 held (+18%) | $8.59 | $163K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 20,432126,146 held (−14%) | $6.76 | $138K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 18,627134,741 held (−12%) | $6.83 | $127K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 17,873116,658 held (+18%) | $6.54 | $117K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 13,856127,533 held (−10%) | $7.57 | $105K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 13,840134,741 held (+11%) | $7.12 | $99K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 11,002128,884 held (+9%) | $8.14 | $90K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 11,129128,884 held (−8%) | $7.94 | $88K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 10,859128,884 held (−8%) | $8.11 | $88K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 12,125126,146 held (+11%) | $6.78 | $82K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 10,734127,533 held (+9%) | $7.64 | $82K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 9,111126,037 held (−7%) | $7.86 | $72K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 7,077126,519 held (−5%) | $8.63 | $61K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 8,894134,741 held (+7%) | $6.86 | $61K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 7,509128,884 held (+6%) | $7.91 | $59K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 7,271126,037 held (+6%) | $7.81 | $57K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 2,201134,741 held (−2%) | $7.05 | $16K | — | 0 |
| Nov 19SEC | HRT Financial LP10% Owner | Sell | 152127,533 held (−0%) | $8.10 | $1K | — | 0 |
| Nov 19SEC | HRT Financial LP10% OwnerFirst buyPast buys 0/8 beat S&P | Buy | 2127,533 held (+0%) | $8.09 | $16 | — | 0 |
Similar past setups: not applicable. There aren't enough comparable past cases for BIAF's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with BIAF in the Research Lab
Pre-set to BIAF's latest insider buy of $10K or more (Nov 19, 2026: HRT Financial LP, $1.0M). Tap to change anything.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Price history unavailable.
bioAffinity Technologies insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $1.0M and 1 sold $1.2M of BIAF stock on the open market.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings · How we calculate this
BIAF insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | $117K | 1 | $268K | 1 |
| Q3 2026 | $923K | 10 | $907K | 10 |
Valuation, profit and volume
Source: Yahoo Finance, as of Nov 20, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 1 bioAffinity Technologies, Inc. insider reported open-market purchases totaling $1.0M, while 1 insider reported sales totaling $1.2M. Among insiders with enough purchase history to measure, HRT Financial LP (10% Owner) has the highest Insider Score at 0. 0 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
BIAF stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
What happened after BIAF insiders bought
Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.
| Filed | Insider | Bought | 7 days | 30 days | 90 days |
|---|---|---|---|---|---|
| Nov 19, 2026 | HRT Financial LP10% Owner | $1.0M | pending | pending | pending |
Insiders at bioAffinity Technologies, Inc.
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| HRT Financial LP10% Owner | $1.0M | $1.2M | Nov 19, 2026 | 0 of 8 | 0 |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
BIAF stock: common questions
Are bioAffinity Technologies, Inc. insiders buying BIAF stock?
In the past 12 months, 1 insider reported open-market purchases of BIAF worth $1.0M. The latest was 10% Owner Hrt Financial Lp bought $231K of BIAF at $7.67 — largest purchase by this insider in our records; raises the stake by 30%.
Are bioAffinity Technologies, Inc. insiders selling BIAF stock?
1 insider reported sales worth $1.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.